AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34581703 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light therapy (10,000 lux) for 30 minutes in the early morning
Number of subjects: 56
Study 34581703 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 56
Study 34581703 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light therapy
Number of subjects: 56
Study 35528160 — intervention group
Group type: EXPERIMENTAL
Intervention: S. boulardii in addition to bismuth quadruple therapy (BQT)
Number of subjects: 180
Study 35528160 — intervention group
Group type: COMPARATOR
Intervention: bismuth quadruple therapy (BQT)
Number of subjects: 180
Study 35191643 — intervention group
Group type: EXPERIMENTAL
Intervention: HFJV
Number of subjects: 75
Study 35191643 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA
Number of subjects: 75
Study 35191643 — intervention group
Group type: COMPARATOR
Intervention: ETT
Number of subjects: 75
Study 34815540 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored approach to informing relatives (probands preferred to inform relatives themselves or by genetic counsellor)
Number of subjects: 482
Study 34815540 — intervention group
Group type: COMPARATOR
Intervention: Current practice (control group)
Number of subjects: 482
Study 34815540 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored approach to informing relatives
Number of subjects: 482
Study 33789481 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular impulse technology (VIT)
Number of subjects: 100
Study 33789481 — intervention group
Group type: COMPARATOR
Intervention: Elevation (control)
Number of subjects: 100
Study 33740060 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted iron concentration
Number of subjects: 125915
Study 33740060 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted vitamin B‐12 concentration
Number of subjects: 125915
Study 33740060 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted selenium concentration
Number of subjects: 125915
Study 33740060 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted zinc concentration
Number of subjects: 125915
Study 33740060 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted concentrations of β‐carotene, calcium, copper, folate, magnesium, phosphorus, and vitamin B‐6
Number of subjects: 125915
Study 35851956 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention (8-week duration)
Number of subjects: 69
Study 35851956 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 69
Study 35851956 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 69
Study 34449866 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope
Number of subjects: 33
Study 34449866 — intervention group
Group type: COMPARATOR
Intervention: i-view
Number of subjects: 33
Study 36394261 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-sternotomy AVR
Number of subjects: 270
Study 36394261 — intervention group
Group type: COMPARATOR
Intervention: Conventional median sternotomy AVR
Number of subjects: 270
Study 36394261 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 270
Study 33006220 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforcement message (RM) provided by a hospital pharmacist for 10 minutes
Number of subjects: 40
Study 33006220 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (Control group)
Number of subjects: 40
Study 32981123 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI with a telephone booster
Number of subjects: 596
Study 32981123 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 596
Study 32981123 — intervention group
Group type: COMPARATOR
Intervention: Brief advice
Number of subjects: 596
Study 35914961 — intervention group
Group type: EXPERIMENTAL
Intervention: $1,000 cash reward policy
Number of subjects: 3698
Study 35914961 — intervention group
Group type: EXPERIMENTAL
Intervention: Employer mandates
Number of subjects: 3698
Study 35914961 — intervention group
Group type: EXPERIMENTAL
Intervention: Other mandate policies
Number of subjects: 3698
Study 35914961 — intervention group
Group type: COMPARATOR
Intervention: Financial incentives (lotteries and cash)
Number of subjects: 3698
Study 32044260 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar locking plate intervention in elderly patients
Number of subjects: 116
Study 32044260 — intervention group
Group type: COMPARATOR
Intervention: Volar locking plate intervention in younger patients
Number of subjects: 116
Study 35181350 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (Dapa)
Number of subjects: 52
Study 35181350 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Con)
Number of subjects: 52
Study 34128075 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cardioversion (1 to 5 days from hospitalization)
Number of subjects: 1039
Study 34128075 — intervention group
Group type: COMPARATOR
Intervention: Delayed cardioversion (21 to 56 days from hospitalization)
Number of subjects: 1039
Study 34128075 — intervention group
Group type: EXPERIMENTAL
Intervention: CHADS2 score of 0
Number of subjects: 1039
Study 34128075 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous restoration of sinus rhythm
Number of subjects: 1039
Study 32558215 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative observations
Number of subjects: 357
Study 35362362 — intervention group
Group type: EXPERIMENTAL
Intervention: Single one-hour visit to a health coach (n=52)
Number of subjects: 105
Study 35362362 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group, n=53)
Number of subjects: 105
Study 33621350 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D multipath DenseNet
Number of subjects: 258
Study 33621350 — intervention group
Group type: COMPARATOR
Intervention: 3D singlepath DenseNet
Number of subjects: 258
Study 32735501 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole combined with levodopa
Number of subjects: 160
Study 32735501 — intervention group
Group type: COMPARATOR
Intervention: Levodopa alone
Number of subjects: 160
Study 35815287 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy (three drops of rosemary essential oil during SWL)
Number of subjects: 176
Study 35815287 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Therapy (soft music played during SWL)
Number of subjects: 176
Study 35815287 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Music Therapy and Aromatherapy (soft music and three drops of rosemary essential oil during SWL)
Number of subjects: 176
Study 35815287 — intervention group
Group type: COMPARATOR
Intervention: Control (three drops of aromatic distilled water during SWL)
Number of subjects: 176
Study 32744424 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 170
Study 32744424 — intervention group
Group type: COMPARATOR
Intervention: Conventional nasal cannula (CNC)
Number of subjects: 170
Study 32510696 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg/kg/day of SENO
Number of subjects: 65
Study 32510696 — intervention group
Group type: COMPARATOR
Intervention: 750 mg/kg/day of placebo-control
Number of subjects: 65
Study 34332946 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-month DAPT after PF-DCS (n = 1,507)
Number of subjects: 3020
Study 34332946 — intervention group
Group type: COMPARATOR
Intervention: 6- to 12-month DAPT after BP-DES (n = 1,513)
Number of subjects: 3020
Study 34332946 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-month DAPT after PF-DCS
Number of subjects: 3020
Study 34332946 — intervention group
Group type: COMPARATOR
Intervention: 6- to 12-month DAPT after BP-DES
Number of subjects: 3020
Study 33267827 — intervention group
Group type: EXPERIMENTAL
Intervention: CHAPS intervention
Number of subjects: 5
Study 33267827 — intervention group
Group type: EXPERIMENTAL
Intervention: CHAPS nurse care managers
Number of subjects: 5
Study 33267827 — intervention group
Group type: EXPERIMENTAL
Intervention: Notebook self-care tool
Number of subjects: 5
Study 33267827 — intervention group
Group type: EXPERIMENTAL
Intervention: Siebens Domain Management Model
Number of subjects: 5
Study 34919121 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse practitioners
Number of subjects: 0
Study 34919121 — intervention group
Group type: COMPARATOR
Intervention: Physicians
Number of subjects: 0
Study 33285722 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing care and follow-up program
Number of subjects: 0
Study 33285722 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33794724 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy-donor-stool transplant
Number of subjects: 9
Study 33794724 — intervention group
Group type: COMPARATOR
Intervention: Self-stool transplant (control)
Number of subjects: 9
Study 33648915 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab
Number of subjects: 0
Study 35254169 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine (TM) follow-up via videoconferencing
Number of subjects: 122
Study 35254169 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine (TM) follow-up
Number of subjects: 122
Study 35254169 — intervention group
Group type: COMPARATOR
Intervention: Standard follow-up (SF)
Number of subjects: 122
Study 33006975 — intervention group
Group type: EXPERIMENTAL
Intervention: Student’s t based compound distributions (six types)
Number of subjects: 0
Study 33006975 — intervention group
Group type: EXPERIMENTAL
Intervention: GARCH models with innovations following the compound distributions
Number of subjects: 0
Study 36013257 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative pectoralis nerve II block (PECS II block)
Number of subjects: 30
Study 36013257 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 32331006 — intervention group
Group type: EXPERIMENTAL
Intervention: OLZ/SAM (olanzapine/samidorphan)
Number of subjects: 281
Study 34187835 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 282
Study 34187835 — intervention group
Group type: COMPARATOR
Intervention: Standard care plus Monitoring Only
Number of subjects: 282
Study 33372081 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural change intervention (dietary, physical activity, and sedentary behaviours) delivered by dietitians over 12 weeks.
Number of subjects: 21
Study 33372081 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 21
Study 33423188 — intervention group
Group type: EXPERIMENTAL
Intervention: Bushen Yiqi Huoxue Decoction (BYHD)
Number of subjects: 180
Study 33423188 — intervention group
Group type: EXPERIMENTAL
Intervention: Zuogui Pill
Number of subjects: 180
Study 33423188 — intervention group
Group type: COMPARATOR
Intervention: Progynova and Duphaston (E+D)
Number of subjects: 180
Study 32462670 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD/SL intervention applied in groups 2018/2 and 2019/1
Number of subjects: 191
Study 32462670 — intervention group
Group type: COMPARATOR
Intervention: Control group (2018/1) without ICD/SL
Number of subjects: 191
Study 32462670 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD/SL intervention
Number of subjects: 191
Study 36114537 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental arm (six-month intervention combining hard levers - free access to transport/bikes, and soft levers - personalized transport advice)
Number of subjects: 300
Study 36114537 — intervention group
Group type: COMPARATOR
Intervention: Control arm (six-month intervention aimed at raising awareness on air pollution and its health effects)
Number of subjects: 300
Study 36114537 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (evaluation weeks based on GPS, accelerometer, and pollution sensor)
Number of subjects: 300
Study 33305369 — intervention group
Group type: COMPARATOR
Intervention: NSAID users (n = 655)
Number of subjects: 2999
Study 35345897 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic self-training (ReoGo-J) plus conventional therapy (robotic therapy)
Number of subjects: 129
Study 35345897 — intervention group
Group type: COMPARATOR
Intervention: Conventional self-training plus conventional therapy (control)
Number of subjects: 129
Study 35345897 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic self-training plus constraint-induced movement therapy
Number of subjects: 129
Study 33772279 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 330
Study 33772279 — intervention group
Group type: COMPARATOR
Intervention: Observation after adjuvant chemotherapy
Number of subjects: 330
Study 32865357 — intervention group
Group type: COMPARATOR
Intervention: Conventional subgingival scaling and root planing (SRP) (n=7, 408 sites)
Number of subjects: 13
Study 32865357 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP using periodontal endoscope (n=4, 188 sites)
Number of subjects: 13
Study 32865357 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP with periodontal endoscope 3 months after initial SRP (n=2, 142 sites)
Number of subjects: 13
Study 35666651 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led navigation (PLNav) intervention
Number of subjects: 45
Study 35666651 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 45
Study 32430524 — intervention group
Group type: EXPERIMENTAL
Intervention: PL group (laparoscopic approach)
Number of subjects: 149
Study 32430524 — intervention group
Group type: COMPARATOR
Intervention: M group (midline incision)
Number of subjects: 149
Study 32430524 — intervention group
Group type: COMPARATOR
Intervention: L group (conventional inverted L incision)
Number of subjects: 149
Study 32430524 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 149
Study 32034769 — intervention group
Group type: EXPERIMENTAL
Intervention: PET-CT
Number of subjects: 404
Study 32034769 — intervention group
Group type: COMPARATOR
Intervention: No PET-CT
Number of subjects: 404
Study 33271506 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity interval training
Number of subjects: 197
Study 33271506 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity continuous training
Number of subjects: 197
Study 33271506 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity continuous training plus interval training
Number of subjects: 197
Study 33271506 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 197
Study 36074149 — intervention group
Group type: EXPERIMENTAL
Intervention: ImmunoPET with [89Zr]Zr‐DFO‐ATZ
Number of subjects: 4
Study 35851754 — intervention group
Group type: EXPERIMENTAL
Intervention: Telitacicept 240 mg every week for 46 times after plasma exchange
Number of subjects: 8
Study 34504196 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rifaximin (550 mg twice daily for 7-10 or 14-21 days preoperatively and 7 days postoperatively)
Number of subjects: 35
Study 34504196 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 35
Study 34504196 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rifaximin
Number of subjects: 35
Study 35078666 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-003 (DENV-2-based dengue tetravalent vaccine candidate)
Number of subjects: 67
Study 35321144 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR) 2x1 min
Number of subjects: 20
Study 35321144 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR) 2x3 min
Number of subjects: 20
Study 35321144 — intervention group
Group type: COMPARATOR
Intervention: Control (no foam rolling)
Number of subjects: 20
Study 35072713 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 1273
Study 35072713 — intervention group
Group type: EXPERIMENTAL
Intervention: HFNO
Number of subjects: 1273
Study 35072713 — intervention group
Group type: COMPARATOR
Intervention: Conventional oxygen therapy
Number of subjects: 1273
Study 34793638 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 63
Study 34793638 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 63
Study 34534232 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.35% ropivacaine with a volume of 14ml for male patients
Number of subjects: 101
Study 34534232 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.353% ropivacaine with a volume of 12ml for female patients
Number of subjects: 101
Study 34534232 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% ropivacaine with a volume of 14ml for male and 12ml for female
Number of subjects: 101
Study 32501546 — intervention group
Group type: COMPARATOR
Intervention: SBP control at less than 50% of visits
Number of subjects: 6591
Study 32501546 — intervention group
Group type: EXPERIMENTAL
Intervention: SBP control at 50% to less than 75% of visits
Number of subjects: 6591
Study 32501546 — intervention group
Group type: EXPERIMENTAL
Intervention: SBP control at 75% to less than 100% of visits
Number of subjects: 6591
Study 32501546 — intervention group
Group type: EXPERIMENTAL
Intervention: SBP control at 100% of visits
Number of subjects: 6591
Study 35698194 — intervention group
Group type: EXPERIMENTAL
Intervention: CARST (computer-aided reconstruction of soft tissue)
Number of subjects: 30
Study 35698194 — intervention group
Group type: COMPARATOR
Intervention: Traditional soft tissue reconstruction
Number of subjects: 30
Study 33554343 — intervention group
Group type: EXPERIMENTAL
Intervention: amiRNA targeting CBF transcription factors
Number of subjects: 6
Study 33554343 — intervention group
Group type: EXPERIMENTAL
Intervention: amiRNA targeting ERF34 and ERF35 transcription factors
Number of subjects: 6
Study 32265495 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan tampon (Hemoblock‐Tampon)
Number of subjects: 61
Study 33563100 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone training intervention
Number of subjects: 26
Study 34024754 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 99
Study 34024754 — intervention group
Group type: COMPARATOR
Intervention: Usual-treatment
Number of subjects: 99
Study 35475907 — intervention group
Group type: COMPARATOR
Intervention: 15 g oral glucose (CHO)
Number of subjects: 20
Study 35475907 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 µg dasiglucagon (D80)
Number of subjects: 20
Study 35475907 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 µg dasiglucagon (D120)
Number of subjects: 20
Study 35644368 — intervention group
Group type: EXPERIMENTAL
Intervention: Health coaching for parents of CMCs (3-6 months)
Number of subjects: 125
Study 35644368 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 125
Study 33629506 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction diet with fiber supplementation (10 g day-1 inulin + 10 g day-1 resistant maltodextrin)
Number of subjects: 80
Study 33629506 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 80
Study 33072209 — intervention group
Group type: EXPERIMENTAL
Intervention: Transformational management properties of hospital managers
Number of subjects: 346
Study 33185050 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/m² PLD (experimental arm)
Number of subjects: 470
Study 33185050 — intervention group
Group type: COMPARATOR
Intervention: 50 mg/m² PLD (standard arm)
Number of subjects: 470
Study 33185050 — intervention group
Group type: COMPARATOR
Intervention: Standard arm (50 mg/m² PLD)
Number of subjects: 470
Study 32972635 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% Pueraria mirifica gel
Number of subjects: 60
Study 32972635 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 60
Study 34080764 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping (KT)
Number of subjects: 50
Study 34080764 — intervention group
Group type: COMPARATOR
Intervention: Sham Kinesiotaping (sham KT)
Number of subjects: 50
Study 33213506 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week integrated treatment
Number of subjects: 214
Study 33213506 — intervention group
Group type: COMPARATOR
Intervention: Gambling only control condition
Number of subjects: 214
Study 34153946 — intervention group
Group type: EXPERIMENTAL
Intervention: Coherent transport regime for a clean wire
Number of subjects: 0
Study 34153946 — intervention group
Group type: EXPERIMENTAL
Intervention: Non‐coherent transport regime with dephasing
Number of subjects: 0
Study 34153946 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of dephasing
Number of subjects: 0
Study 32453183 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation (VNS)
Number of subjects: 19
Study 32453183 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline QTc length
Number of subjects: 19
Study 34811971 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal recorded home oximetry (RHO)
Number of subjects: 53
Study 34811971 — intervention group
Group type: COMPARATOR
Intervention: Polysomnography (PSG)
Number of subjects: 53
Study 32776286 — intervention group
Group type: EXPERIMENTAL
Intervention: SOTOS (silent operation theatre optimisation system)
Number of subjects: 32
Study 32776286 — intervention group
Group type: COMPARATOR
Intervention: Control (no SOTOS)
Number of subjects: 32
Study 32776286 — intervention group
Group type: EXPERIMENTAL
Intervention: SOTOS
Number of subjects: 32
Study 36417447 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-based e-flipped workshop
Number of subjects: 150
Study 36417447 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-based online workshop
Number of subjects: 150
Study 36417447 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 33161779 — intervention group
Group type: EXPERIMENTAL
Intervention: Transverse DMO
Number of subjects: 18
Study 33161779 — intervention group
Group type: COMPARATOR
Intervention: Chevron DMO
Number of subjects: 18
Study 35710599 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 3 mg (LIRA 3 mg)
Number of subjects: 82
Study 35710599 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 82
Study 33470751 — intervention group
Group type: EXPERIMENTAL
Intervention: I-eHealth
Number of subjects: 36
Study 33470751 — intervention group
Group type: COMPARATOR
Intervention: RCT-eHealth
Number of subjects: 36
Study 33470751 — intervention group
Group type: COMPARATOR
Intervention: RCT-control
Number of subjects: 36
Study 35751710 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping in diabetic pregnancies
Number of subjects: 261